Q3 2025 Earnings Call Transcript November 3, 2025 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $2.66, ...

Novo Nordisk’s CEO won’t comment on whether the Danish company will go even higher in its bidding war for Metsera, but said ...

Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...

We are thrilled to welcome Andrew to this newly created senior executive role. His addition comes as Turn Therapeutics enters a new phase of growth following its public listing and strengthened ...

It's an unspoken duty to your dog and the unwavering commitment they had to you while they lived. It's a duty to your own ...

Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find out why SANA stock is a Strong Buy.

BPharmacy has become one of the most sought-after professional courses this year, with 96 per cent of seats filled in ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30 ...

The 18,500-square-foot building offers industry-grade training for biotech technicians and is part of McCord's efforts to brand Generation Park as a premier life sciences hub in Houston.

The surge in biotech breeding has brought new scrutiny to how policies handle risk related to genetic manipulation. The concern isn't just about valuation – it’s about the unk ...